Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals. (Q39705105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Hiroshi Shiku

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

9

Shimon Sakaguchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

10

Lloyd J Old

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Jun Mitsui

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Hiroyoshi Nishikawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Daisuke Muraoka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Linan Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Takuro Noguchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Eiichi Sato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Satoshi Kondo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Takuma Kato

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

11 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

2781-2791

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

Immune recognition of self in immunity against cancer

2 February 2020

cites work

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Inhibition of murine gammadelta lymphocyte expansion and effector function by regulatory alphabeta T cells is cell-contact-dependent and sensitive to GITR modulation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

NY-ESO-1: review of an immunogenic tumor antigen

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

CTLA-4 control over Foxp3+ regulatory T cell function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Perspectives of gammadelta T cells in tumor immunology

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Cancer immunotherapy: moving beyond current vaccines

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Human T cell responses against melanoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

A function for interleukin 2 in Foxp3-expressing regulatory T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Effector and memory CTL differentiation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Engagement of glucocorticoid-induced TNF receptor costimulates NKT cell activation in vitro and in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8+ T cells.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

CTLA-4: new insights into its biological function and use in tumor immunotherapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

A colon tumor model for anticancer agent evaluation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1078-0432.CCR-09-3243

Identifiers

DOI

10.1158/1078-0432.CCR-09-3243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20460483%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference